| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $160.5M | +16.7% |
| Cost of Revenue | $131.9M | +21.8% |
| Gross Profit | $28.7M | -2.3% |
| R&D Expense | $4.9M | +9.4% |
| SG&A Expense | $70.3M | -10.6% |
| Operating Income | -$146.4M | -108.7% |
| Interest Expense | $8.2M | +27.3% |
| Pre-tax Income | -$138.6M | -90.4% |
| Income Tax | -$8.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.3M | +38.0% |
| Accounts Receivable | $26.7M | +64.3% |
| Inventory | $1.5M | +113.5% |
| Current Assets | $96.2M | +74.2% |
| Total Assets | $257.7M | -1.6% |
| Current Liabilities | $94.7M | +84.9% |
| Long-term Debt | $77.3M | -0.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.7M | +15.3% |
| Capital Expenditures | $3.6M | +73.2% |
| Investing Cash Flow | -$37.4M | +3.0% |
| Financing Cash Flow | $76.6M | +3.2% |
| Free Cash Flow | -$35.3M | +10.6% |
| +29.3% |
| Net Income | -$130.6M | -112.3% |
| EPS (Basic) | -$2.09 | -53.7% |
| EPS (Diluted) | -$2.09 | -53.7% |
| Total Liabilities |
| $187.8M |
| +21.5% |
| Stockholders' Equity | -$6.7M | -106.2% |